- Home
- SOHO vs LGVN Comparison
SOHO vs LGVN Comparison
Compare SOHO & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOHO
- LGVN
- Stock Information
- Founded
- SOHO 2004
- LGVN 2014
- Country
- SOHO United States
- LGVN United States
- Employees
- SOHO N/A
- LGVN N/A
- Industry
- SOHO Real Estate Investment Trusts
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- SOHO Real Estate
- LGVN Health Care
- Exchange
- SOHO Nasdaq
- LGVN Nasdaq
- Market Cap
- SOHO 21.5M
- LGVN 25.2M
- IPO Year
- SOHO 2004
- LGVN 2021
- Fundamental
- Price
- SOHO $0.86
- LGVN $1.72
- Analyst Decision
- SOHO Hold
- LGVN Strong Buy
- Analyst Count
- SOHO 1
- LGVN 3
- Target Price
- SOHO $1.50
- LGVN $8.67
- AVG Volume (30 Days)
- SOHO 49.3K
- LGVN 288.2K
- Earning Date
- SOHO 03-05-2025
- LGVN 02-25-2025
- Dividend Yield
- SOHO N/A
- LGVN N/A
- EPS Growth
- SOHO N/A
- LGVN N/A
- EPS
- SOHO N/A
- LGVN N/A
- Revenue
- SOHO $179,860,606.00
- LGVN $1,852,000.00
- Revenue This Year
- SOHO N/A
- LGVN $208.32
- Revenue Next Year
- SOHO $0.70
- LGVN $43.96
- P/E Ratio
- SOHO N/A
- LGVN N/A
- Revenue Growth
- SOHO 3.98
- LGVN 141.46
- 52 Week Low
- SOHO $0.81
- LGVN $0.77
- 52 Week High
- SOHO $1.54
- LGVN $8.93
- Technical
- Relative Strength Index (RSI)
- SOHO 37.81
- LGVN 43.65
- Support Level
- SOHO $0.81
- LGVN $1.65
- Resistance Level
- SOHO $0.93
- LGVN $1.89
- Average True Range (ATR)
- SOHO 0.06
- LGVN 0.14
- MACD
- SOHO -0.00
- LGVN -0.00
- Stochastic Oscillator
- SOHO 28.37
- LGVN 11.86
About SOHO Sotherly Hotels Inc.
Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.